

Aminophylline is getting harder to find in 2026. Learn why this bronchodilator faces supply issues, what's behind the shortage, and what you can do.
You've been prescribed Aminophylline for your breathing problems, but when you go to fill the prescription, your pharmacy tells you it's unavailable. Or maybe your doctor wants to use it during a hospital stay, and the supply is limited. Either way, it's frustrating — and in 2026, it's happening more often than ever.
Aminophylline is a medication that's been around for decades. It's a trusted bronchodilator used to help people breathe easier when they have asthma, COPD, emphysema, or chronic bronchitis. But finding it has become a real challenge. Let's break down what's going on and what you can do about it.
Aminophylline is a combination of two compounds: Theophylline and ethylenediamine. Theophylline is the active ingredient — it relaxes the muscles around your airways, opens them up, and makes breathing easier. The ethylenediamine helps Theophylline dissolve better, especially in IV (intravenous) solutions.
Aminophylline belongs to a class of drugs called methylxanthines. It works by inhibiting certain enzymes (phosphodiesterases) and blocking adenosine receptors, which together help relax airway muscles and reduce inflammation. If you'd like to learn more about how it works, check out our detailed guide on how Aminophylline works.
For years, Aminophylline was available as oral tablets, liquid, and IV injections. It was a go-to treatment for acute asthma attacks and COPD flare-ups, especially in emergency rooms and hospitals.
There are several reasons Aminophylline has become difficult to find. Here's what's driving the problem:
This is the biggest reason many patients can't find Aminophylline. The oral tablets (100 mg and 200 mg) and oral solution have been discontinued by manufacturers in the United States. Brand names like Phyllocontin and Truphylline are no longer made. This wasn't because of safety concerns — it was a business decision. As newer inhaled medications like albuterol inhalers and inhaled corticosteroids became the standard of care, demand for oral Aminophylline dropped, and manufacturers stopped producing it.
Aminophylline is still available as an IV injection (25 mg/mL), which hospitals use for acute asthma attacks and severe COPD exacerbations. However, this injectable form has experienced intermittent shortages. Like many older generic injectables, Aminophylline IV is made by a small number of manufacturers, making the supply chain fragile. When one manufacturer has a production issue, it can ripple through the entire market.
Because Aminophylline is an older, low-cost generic drug, there's little financial incentive for new companies to start making it. The few manufacturers that do produce it can't always keep up with demand, especially during surges in respiratory illness. This is a common problem across the generic injectable drug market.
Modern treatment guidelines for asthma and COPD favor inhaled therapies — like beta-2 agonist inhalers and inhaled corticosteroids — over oral methylxanthines. Aminophylline and Theophylline are now considered third-line treatments in most cases. This reduced demand further discourages manufacturers from maintaining production. For more on what's happening with supply, read our Aminophylline shortage update for 2026.
If you're having trouble getting Aminophylline, here are some practical steps:
Since Aminophylline releases Theophylline in your body, oral Theophylline extended-release tablets (like Theo-24) are the most direct substitute. They're still manufactured and widely available in the US, with prices starting around $26 for a 30-day supply with a discount card. Your doctor can switch your prescription with a simple dosage adjustment.
If you need to find a pharmacy that has Aminophylline (or Theophylline) in stock, Medfinder can help. Our tool checks availability at pharmacies near you in real time, so you don't have to call around yourself. Learn more in our guide on how to find Aminophylline in stock near you.
If Theophylline isn't right for you either, there are other options. Dyphylline is another methylxanthine bronchodilator with a wider safety margin. Montelukast (Singulair) and Tiotropium (Spiriva) work through different mechanisms but can also help manage asthma and COPD. Read our full breakdown of alternatives to Aminophylline.
Large chain pharmacies may run out of certain medications faster than smaller, independent pharmacies. It's worth calling local independent pharmacies or asking about compounding pharmacies that might be able to prepare a custom formulation.
Even if you find Aminophylline or its alternatives, cost can be a barrier. Discount cards from GoodRx, SingleCare, and other providers can help bring down the price. For more tips, see our article on how to save money on Aminophylline.
Aminophylline has been a valuable medication for decades, but changes in the pharmaceutical landscape have made it harder to access — particularly the oral form, which is no longer available in the US. The IV form remains in use but faces its own supply challenges.
The good news is that alternatives exist. Theophylline ER is the closest substitute and is still widely available. Your doctor can help you find the right option, and tools like Medfinder can help you locate it in stock near you.
Don't let a shortage keep you from breathing easier. Reach out to your healthcare provider, explore your options, and use every tool available to stay on top of your care.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.